Moderna's GAAP loss for 9 months of 2023 was $4.931 billion, against a profit of $6.897 billion in the prior year. Revenue decreased 3.5 times to $4.037 bln vs. $14.179 bln a year earlier.

Moderna's GAAP loss for 6 months of 2023 was $1.301 billion, against a profit of $5.854 billion in the prior year. Revenue declined 5-fold to $2.206 billion versus $10.815 billion a year earlier.

Moderna's GAAP net income for 3 months of 2023 was $0.079 billion, down many times from $3.657 billion in the previous year. Revenue decreased 3.3 times to $1.862 billion from $6.066 billion a year earlier.

Moderna's GAAP net income for 2022 was $8.362 billion, down 31.5% from $12.202 billion the previous year. Revenue increased 4.3% to $19.263 billion from $18.471 billion a year earlier.